Tevogen Bio Holdings Inc. (TVGNW)
USD 0.04
(3.96%)
USD 0.04
(3.96%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -1.37 Million | -215.39 Thousand | -5.27 Million |
| Net Income | -67.32 Thousand | 4.4 Million | -15.59 Million |
| Depreciation & Amortization | 378.36 | 230.82 Thousand | 9377.00 |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | 4578.73 | 582.41 |
| Change in working capital | 897.61 Thousand | 737.68 Thousand | -1.24 Million |
| Other non-cash items | 256.03 Thousand | 8.31 Million | 10.97 Million |
| Investing Cash Flow | 342.91 Million | -479.04 | -109.72 Thousand |
| Investments in PPE | -133.00 | -479.04 Thousand | -109.72 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | -67.5 Thousand | - | -351.9 Million |
| Sales/Maturities of investments | 342.98 Million | - | - |
| Other Investing Activities | 342.91 Million | - | - |
| Financing Cash Flow | -341.66 Million | 7500.00 | 12.5 Million |
| Debt repayment | -1.32 Million | -7500.00 | -12.5 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | -342.98 Million | - | - |
| Common Stock Issuance | - | - | 352.95 Million |
| Other Financing Activities | -127.75 | - | - |
| Accounts receivables | -267 Thousand | - | - |
| Accounts payables | 931.95 Thousand | 171.07 Thousand | -1.09 Million |
| Inventory | - | - | - |
| Other working capital | -34.33 Thousand | 566.6 Thousand | -571.78 Thousand |
| Cash at beginning of period | 129.18 Thousand | 344.58 Thousand | 3838.00 |
| Cash at end of period | 8835.00 | 129.18 Thousand | 7.11 Million |
| Capital Expenditure | -133.00 | -479.04 Thousand | -109.72 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -120.35 Thousand | -215.39 Thousand | 7.11 Million |
| Free Cash Flow | -1.37 Million | -694.43 Thousand | -5.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.05 Million | 11.26 Million | -828.92 Thousand | -67.32 Thousand | -278.74 Thousand | -22.18 Million |
| Depreciation & Amortization | 99.99 Thousand | 98.3 Thousand | 259.15 Thousand | 378.36 | 39.73 Thousand | -11.73 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.14 Million | 26.33 Million | - | - | - | - |
| Change in working capital | 1.37 Million | 517.83 Thousand | -46.2 Thousand | 897.61 Thousand | 397.5 Thousand | -125.86 Thousand |
| Other non-cash items | 339.29 Thousand | -40.41 Million | 40.04 Thousand | 256.03 Thousand | -633.34 Thousand | 20.1 Million |
| Investing Cash Flow | - | - | 9.64 Million | 342.91 Million | - | - |
| Investments in PPE | - | - | - | -133.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -67.5 Thousand | -67.5 Thousand | - | - |
| Sales/Maturities of investments | - | - | 9.71 Million | 342.98 Million | - | - |
| Other Investing Activities | - | - | - | 342.91 Million | - | - |
| Financing Cash Flow | 2.8 Million | 2.42 Million | -9.29 Million | -341.66 Million | 950 Thousand | 901 Thousand |
| Debt repayment | - | - | -422.5 Thousand | -1.32 Million | -1.15 Million | -901 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -9.71 Million | -342.98 Million | -333.27 Million | - |
| Common Stock Issuance | - | 2 Million | - | - | 333.27 Million | - |
| Other Financing Activities | 2.8 Million | 229.32 Thousand | 72.25 Thousand | -127.75 | -200 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.45 Million | 1.69 Million | 141.36 Thousand | 931.95 Thousand | 306.11 Thousand | -124.86 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -80.02 Thousand | -1.17 Million | -187.57 Thousand | -34.33 Thousand | 91.38 Thousand | -80.53 Thousand |
| Cash at beginning of period | 1.31 Million | 1.05 Million | 347.54 Thousand | 129.18 Thousand | 556.01 Thousand | 5.67 Million |
| Cash at end of period | 1.13 Million | 1.31 Million | 8835.00 | 8835.00 | 347.54 Thousand | 3.45 Million |
| Capital Expenditure | - | - | - | -133.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -182.51 Thousand | 265.5 Thousand | -338.71 Thousand | -120.35 Thousand | -208.46 Thousand | -2.21 Million |
| Free Cash Flow | -2.98 Million | -2.16 Million | -693.71 Thousand | -1.37 Million | -208.46 Thousand | -2.21 Million |
AAATECH
SM
LMNR
CARBORUNIV
MOVE
6931